A case-control study of uterine endometrial cancer of pre- and post-menopausal women

Oncology Reports

Volumn 7, Issue 1, 2000, Pages 89-93

  Niwa, Kenji ^a   Imai, Atushi ^a   Hashimoto, Midori ^a   Yokoyama, Yasuhiro ^a   Mori, Hideki ^a   Matsuda, Yoshiyasu ^b   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Economic and Industrial Promotion Center   (Japan)

Author keywords

Case control study; Endometrial cancer; Epidemiology; p53; Risk factor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MIDDLE AGED; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 0033627587     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.1.89     Document Type: Article

References (26)

1. Masubuchi K, Nemoto H, Masubuchi S, Fujimoto I and Uchino S: Increasing incidence of endometrial carcinoma in Japan. Gynecol Oncol 3: 335-346, 1975.
2. Tsutui A: Epidemiology of endometrial cancer. Pract Obstet Gynecol (in Japanese) 37: 831-839, 1988.
3. Itoh N, Niwa K, Horibe S, Nakanishi Y, Itoh T, Sugiyama M, Kawazoe K, Morishita S and Tamaya T: Studies on clinico-pathological epidemiology of uterine carcinoma from 1984 to 1993 at the Department of Obstetrics and Gynecology, Gifu University School of Medicine. Acta Sch Med Univ Gifu (in Japanese) 43: 373-376, 1995.
4. Bokhman JV: Two pathogenctic types of endometrial carcinoma. Gynecol Oncol 15: 10-17, 1983.
5. Deligdish L and Holinka CF: Progesterone receptors in two groups of endometrial carcinoma. Cancer 57: 1385-1388, 1986.
6. Honda T, Kato H, Imamura T, Gima T, Nishida J, Sasaki M, Hoshi K, Sato A and Wake N: Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer 53: 963-967, 1993.
7. Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF and Mori T: Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas; inverse correlation with sex steroid receptor status. Virch Arch [A] Pathol Anat 423: 265-271, 1993.
8. Niwa K, Murase T, Morishita S, Itoh N, Mori H, Tanaka T and Tamaya T: p53 Overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status. Cancer Detect Prev (In press).
9. Brinton LA and Hoover RN: Epidemiology of gynecologic cancers. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ, Perez CA and Young RC (eds). J.B. Lippincott Co., Philadelphia, pp3-26, 1992.
10. Olson SH, Trevisan M, Marshall JR, Graham S, Zielezny M, Vena JE, Hellmann R and Freudenheim JL: Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 23: 141-149, 1995.
11. Kalandidi A, Tronou A, Lipworth L, Gamatsi I, Filippa D and Trichopoulos D: A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology 53: 354-359, 1996.
12. Inoue M, Okayama A, Fujita M, Enomoto T, Tanizawa O and Ueshima H: A case-control study on risk factors for uterine endometrial cancer in Japan. Jpn J Cancer Res 85: 346-350, 1994.
13. Noda K: Study of multiple risk factors for endometrial cancer. In: Annual Report of the Ministry Health and Welfare. Ministry of Health and Welfare (in Japanese), Tokyo, pp517-530, 1983.
14. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG and Wilkinson EJ: Histological classification of the female genital tract. In: Histological typing of female genital tract tumours. 2nd edition. WHO, Geneva, pp13-18, 1994.
15. Creasman WT: New gynecologic cancer staging. Obstet Gynecol 75: 287-288, 1994.
16. Kohler MF, Berchuck A, Davidoff AM, Humhrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC and Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52: 1622-1627, 1992.
17. Goldzieher JW: Polycystic ovarian disease. Fertil Steril 35: 371-374, 1989.
18. Haenzel W and Kurihara M: Studies on Japanese migrants. I. Mortality from cancer and other disease among Japanese in the United States. J Natl Cancer Inst 40: 43-68, 1968.
19. Dalgren E, Friberg LG, Johansson S, Lindström B, Odén A, Samsioe G and Janson PO: Endometrial carcinoma: ovarian dysfunction: a risk factor in young women. Eur J Obstet Gynecol Rep Biol 41: 143-150, 1991.
20. Golgzieher JW and Axelrod LR: Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14: 631-365, 1963.
21. Mattson LÅ, Cullberg G and Hamberger L: Lipid metabolism in women with polycystic ovary syndrome; possible implications for increased risk coronary heart disease. Fertil Steril 42: 579-584, 1984.
22. Fechncr RE and Kaufman RH: Endometrial cancer in Stein Levental syndrome. Cancer 34: 444-452, 1974.
23. MacDonald TW, Malkasian FGD and Gaffe F: Endometrial cancer associated with feminizing ovarian tumor and polycystic ovarian disease. Obstet Gynecol 49: 654-658, 1977.
24. Li SF, Shinozawa T, Nakayama K, Nikaido T and Fujii S: Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer 77: 321-329, 1996.
25. Lax SF, Pizer ES, Ronnett BM and Kurman RJ: Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen and progesterone receptor expression. Hum Pathol 29: 551-558, 1998.
26. Murase T, Niwa K, Morishita S, Itoh N, Mori H, Tanaka T and Tamaya T: Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17β-estradiol. Cancer Lett 97: 223-227, 1995.